Abstract
Recent data has shown that for oropharyngeal squamous cell carcinoma (OPSCC), p16 positivity (p16+), a surrogate for HPV, portends a better prognosis. At Washington University, the most frequent approach for OPSCC is minimally invasive transoral laser microsurgery (TLM) with adjuvant radiotherapy (RT) or chemoradiotherapy (CRT). This retrospective review compares outcomes for OPSCC p16+ patients treated with adjuvant RT or CRT.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
